Daslemia 50mg (Dasatinib (50mg))

Daslemia 50mg Tablet contains Dasatinib, which is primarily used in the treatment of certain types of blood cancers, particularly chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). By targeting specific cellular processes, it helps manage the disease by inhibiting the growth of cancer cells. This targeted approach aims to improve the overall health and quality of life for patients facing these challenging conditions.

Dasatinib works by blocking signals that promote the growth and spread of cancer cells. It interferes with proteins that are crucial for the survival and proliferation of these cells, which contributes to reducing their numbers in the body. This mechanism is focused on halting the progression of the disease and potentially leading to better health outcomes for patients.

For best results with Daslemia, it is important to store the tablets in a cool, dry place away from direct sunlight. Consistency in taking the medication as directed is key to its effectiveness. Patients should also be aware of general safety precautions, including informing their healthcare provider about any other medications they are taking or any pre-existing health conditions.

Some common side effects may include mild symptoms such as headaches, fatigue, or nausea. These effects may vary from person to person, and it is important to discuss any concerns with a healthcare professional.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.